President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareBillingInfo for Healthcare ProfessionalsDiabetes Information & Resources
Clinical Research50-Year Medalist Study
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternational
Give NowGet InvolvedEventsTributes & Special OccasionsCorporate & Foundation EngagementLegacy GivingWays to GivePhilanthropy TeamPublications

Diabetes Eye Research Trials and Achievements

The Beetham Eye Institute is the world leader in research to identify the causes of diabetic eye disease and to find new therapies to lessen the risks of visual loss.

Director Lloyd Paul Aiello, M.D. is chairperson of the Diabetic Retinopathy Clinical Research Network, which involves Joslin in nearly every major clinical trial of the treatment and prevention of diabetic retinopathy and macular edema in the United States. Click here to learn about the Joslin Section on Eye Research.

Recent clinical trials have included the evaluation of such innovative therapies as:

Enrolling in a Clinical Trial

Patients at the Beetham Eye Institute may be eligible to participate in clinical trials. For information on our clinical trials, call 617-732-2586.

Click here for information on current clinical trials that are looking for volunteers.

Joslin’s Beetham Eye Institute is named after William P. Beetham, M.D, who with founding director Lloyd M. Aiello, M.D., helped pioneer laser surgery for diabetic eye disease.

This procedure is the gold-standard treatment for advanced diabetic retinopathy worldwide and has helped hundreds of thousands of people with diabetes preserve their vision.

Page last updated: November 07, 2019